LSA
TGTX icon

Leonteq Securities AG’s TG Therapeutics TGTX Stock Holding History

Leonteq Securities AG’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,993
Closed -$119K – 1484
2025
Q4 		$119K Buy
3,993
+1,109
+38% +$36.2K ﹤0.01% 770
2025
Q3 		$104K Buy
2,884
+1,546
+116% +$50.9K ﹤0.01% 738
2025
Q2 		$48.2K Buy
1,338
+1,211
+954% +$45.1K ﹤0.01% 855
2025
Q1 		$5.01K Sell
127
-1,119
-90% -$37.7K ﹤0.01% 1100
2024
Q4 		$37.5K Buy
1,246
+596
+92% +$17.1K ﹤0.01% 875
2024
Q3 		$15.2K Buy
650
+150
+30% +$3.28K ﹤0.01% 942
2024
Q2 		$8.89K Sell
500
-300
-38% -$4.79K ﹤0.01% 995
2024
Q1 		$12.2K Buy
+800
New +$12.7K ﹤0.01% 987
2022
Q4 		– Sell
-600
Closed -$3.55K – 1359
2022
Q3 		$3.55K Hold
600
– – ﹤0.01% 1152
2022
Q2 		$2.55K Hold
600
– – ﹤0.01% 1190
2022
Q1 		$5.71K Hold
600
– – ﹤0.01% 1157
2021
Q4 		$11.4K Buy
+600
New +$15.6K ﹤0.01% 1147
2021
Q3 		– Sell
-790
Closed -$30.6K – 1219
2021
Q2 		$30.6K Buy
790
+340
+76% +$13.4K ﹤0.01% 894
2021
Q1 		$21.7K Buy
+450
New +$21.6K ﹤0.01% 877

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Leonteq Securities AG's TGTX Position: Q1 2026 in Review

Leonteq Securities AG sold out of TG Therapeutics (TGTX) in Q1 2026, closing a stake of 3,993 shares — an estimated $119K sold.

Leonteq Securities AG first reported a position in TGTX in Q1 2021 and held it in 14 quarters. The position peaked at $119K in Q4 2025. 365 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Leonteq Securities AG reported no remaining TG Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 3,993 TG Therapeutics shares in Q1 2026, an estimated $119K.
  • Leonteq Securities AG first reported a position in TG Therapeutics in Q1 2021 and held it in 14 quarters.
  • Leonteq Securities AG's TG Therapeutics position peaked at $119K in Q4 2025.
  • 365 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.